Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zanni

Showing results (881-890 of 943) with videos related to

Pageof 95
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2023
Associations of Muscle Density and Area With Coronary Artery Plaque and Physical FunctionKristine M Erlandson, Triin Umbleja, Michael T Lu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2022
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)Samuel R Schnittman, Michael T Lu, Thomas Mayrhofer, et al.
Haematologica|November 17, 2022
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL)Alessandra Tucci, Francesco Merli, Alberto Fabbri, et al.
AIDS (London, England)|May 27, 2025
Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trialChristopher deFilippi, Aya Awwad, Gerald S Bloomfield, et al.
Blood Advances|January 5, 2024
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphomaAnnarita Conconi, Annalisa Chiappella, Andrés J M Ferreri, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2024
Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIVMaheen Z Abidi, Triin Umbleja, Edgar T Overton, et al.
Open Forum Infectious Diseases|June 16, 2025
Prognostic Factors of Physical Function Decline Among Middle-Aged Adults With HIVGrace L Kulik, Triin Umbleja, Todd T Brown, et al.
Open Forum Infectious Diseases|March 31, 2023
Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency VirusSamuel R Schnittman, Douglas W Kitch, Talia H Swartz, et al.
JAMA Cardiology|December 11, 2024
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical TrialMárton Kolossváry, Samuel R Schnittman, Markella V Zanni, et al.
Open Forum Infectious Diseases|October 22, 2024
Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIVMarkella V Zanni, Triin Umbleja, Carl J Fichtenbaum, et al.
Pageof 95

Showing results (881-890 of 943) with videos related to

Sort By:
Pageof 95
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2023
Associations of Muscle Density and Area With Coronary Artery Plaque and Physical FunctionKristine M Erlandson, Triin Umbleja, Michael T Lu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2022
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)Samuel R Schnittman, Michael T Lu, Thomas Mayrhofer, et al.
Haematologica|November 17, 2022
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL)Alessandra Tucci, Francesco Merli, Alberto Fabbri, et al.
AIDS (London, England)|May 27, 2025
Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trialChristopher deFilippi, Aya Awwad, Gerald S Bloomfield, et al.
Blood Advances|January 5, 2024
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphomaAnnarita Conconi, Annalisa Chiappella, Andrés J M Ferreri, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2024
Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIVMaheen Z Abidi, Triin Umbleja, Edgar T Overton, et al.
Open Forum Infectious Diseases|June 16, 2025
Prognostic Factors of Physical Function Decline Among Middle-Aged Adults With HIVGrace L Kulik, Triin Umbleja, Todd T Brown, et al.
Open Forum Infectious Diseases|March 31, 2023
Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency VirusSamuel R Schnittman, Douglas W Kitch, Talia H Swartz, et al.
JAMA Cardiology|December 11, 2024
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical TrialMárton Kolossváry, Samuel R Schnittman, Markella V Zanni, et al.
Open Forum Infectious Diseases|October 22, 2024
Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIVMarkella V Zanni, Triin Umbleja, Carl J Fichtenbaum, et al.
Pageof 95